Aytu BioPharma, Inc.

DB:AY20 Stock Report

Market Cap: €7.7m

Aytu BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AY20?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders170,5834.77%
Institutions609,20917%
General Public2,793,47078.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 126.6%.

Top Shareholders

Top 25 shareholders own 21.55% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.59%
Heights Capital Management, Inc.
163,942€351.3k2,210%0.05%
3%
Renaissance Technologies LLC
107,039€229.4k22.5%no data
2.1%
Alyeska Investment Group, L.P.
75,000€160.7k0%no data
1.67%
Millennium Management LLC
59,497€127.5k190%no data
1.63%
Christopher Brooke
58,357€125.1k0%no data
1.61%
Joshua Disbrow
57,594€123.4k28.3%no data
1.36%
The Vanguard Group, Inc.
48,671€104.3k0.08%no data
1.2%
Dimensional Fund Advisors LP
42,884€91.9k0%no data
0.67%
BlackRock, Inc.
24,059€51.6k-0.12%no data
0.56%
Acadian Asset Management LLC
19,896€42.6k0%no data
0.43%
Wilcoxson Wealth Management
15,477€33.2k47.7%no data
0.36%
Jarrett Disbrow
12,797€27.4k0%no data
0.34%
Geode Capital Management, LLC
12,040€25.8k-0.31%no data
0.27%
Mark Oki
9,500€20.4k90%no data
0.25%
Greg Pyszczymuka
9,103€19.5k0%no data
0.25%
PGIM, Inc.
8,977€19.2k23.4%no data
0.23%
Gary Cantrell
8,204€17.6k-19.6%no data
0.21%
Carl Dockery
7,440€15.9k-26.7%no data
0.19%
Vivian Liu
6,825€14.6k2,000%no data
0.17%
Allred Capital Management, LLC
6,250€13.4k19.1%0.01%
0.14%
State Street Global Advisors, Inc.
4,884€10.5k0%no data
0.13%
Jane Street Group, LLC, Asset Management Arm
4,594€9.8k580%no data
0.073%
Citigroup Inc.,Banking and Securities Investments
2,618€5.6k262,000%no data
0.065%
Northern Trust Global Investments
2,329€5.0k0%no data
0.056%
Group One Trading LP, Asset Management Arm
2,009€4.3k-0.99%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/04/08 13:46
End of Day Share Price 2023/01/10 00:00
Earnings2022/12/31
Annual Earnings2022/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aytu BioPharma, Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jennifer KimCantor Fitzgerald & Co.
Jeffrey CohenLadenburg Thalmann & Company
Nazibur RahmanMaxim Group